Basecamp Research Raises $140 Million for AI Designed Therapeutics
Sep 24, 2026
Funding
OncoC4 Secures $50 Million in Series B Funding for Cancer Therapy Development
Oct 3, 2025
OncoC4, a biotechnology company, has closed a Series B financing round of nearly $50 million to advance its pipeline of cancer therapies, announced in a press release.
OncoC4 has closed a Series B financing round of nearly $50 million, announced in a press release. The round was led by GBA Fund, with participation from the company's co-founders and existing investors, including HM Capital, 3E Bioventures Capital, and Kaitai Capital.
Founded in 2020 by immunologists Dr. Yang Liu and Dr. Pan Zheng, OncoC4 is focused on developing innovative therapies for cancer and neurodegenerative diseases. The funds from this financing round will be used to advance the clinical development of the company's pipeline programs, which target both novel and well-validated targets across oncology and immunological diseases.
Dr. Yang Liu, Co-Founder and CEO of OncoC4, expressed gratitude for the investors' support and emphasized the company's commitment to advancing its core pipeline and expanding business development activities globally.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 KBRA Rated Anthropic BB+ Before $35 Billion Chip Financing Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer BankMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsFree newsletter
AI Funding Brief
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
OpenAI Foundation Gives UNC Lineberger $40 Million for Cancer Vaccine Research
Sep 18, 2026
Biotech
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Sep 19, 2026
Funding
INmune Bio and QCi Apply Quantum Computing to XPro Research
Oct 14, 2026
Life Sciences
Likang to Present AI Cancer Immunotherapy Platform in Abu Dhabi
Oct 14, 2026
Biotech
Immunomatics Receives $100,000 Investment From GenDx Cofounder
Oct 07, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.